• Sign in
  • Sign up 
  • Welcome
  • FAQ
  • Switch to Night Mode
  • Stolen Accounts Recovery 
  • Change Account Password 
  • Vote for Witnesses 
  • Steem Proposals 
  • Third-party exchanges:
  • Poloniex 
  • Advertise 
  • Jobs at Steemit 
  • Developer Portal 
  • Steem Bluepaper 
  • SMT Whitepaper 
  • Steem Whitepaper 
  • Privacy Policy
  • Terms of Service
CondenserPlus
Online–(0 logged in · 0 anonymous)·24 h–(0 logged in · 0 anonymous)·28 d–(0 logged in · 0 anonymous)
EN▾
LoginSign up

Affimed to end cancer program and focus on innate immunity portfolio, shares slide about 10% - MarketWatch

liesizigfa (38)in #dlike • 7 years ago

Shared From Dlike

Clinical stage biotech Affimed N.V. said Wednesday it is terminating its phase I program for AFM11 to focus on its innate immunity portfolio. The company had...


Source of shared Link

#dlike-news
7 years ago in #dlike by liesizigfa (38)
100%
    10%25%50%75%100%
    $0.00
    • Max accepted payout: $900.00
    3 votes
    • + dlike
    • - mack-bot
    • - spaminator
    Reply 0